JADDP 2016-007 JADA vs J-4516
January 6, 2017
In October 2016 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4516 (the Athlete) after his A and B samples tested positive for the prohibited substance methylhexaneamine (dimethylpentylamine).
After notification a provisional suspension was ordered. The Athlete filed a statement with evidence in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel (JADDP).
The Athlete explained that he took a vitamin supplement since January 2015 and mentioned this on the Doping Control Form. He asserted that this supplement was the source of the positive test result and argued that the supplement was recommended by his Football Club and considered as “being confirmed not to contain any prohibited substance”. Statements and evidence from several officials, JADA and the laboratory test report confirmed that the prohibited substance was found in this recommended supplement.
Considering the statements and circumstances in this case the Panel finds that reasonably can be presumed that the prohibited substance was detected in the supplement and that the Athlete cannot be recognized to have lacked fault or negligence or significant fault or negligence.
Therefore the Japan Anti-Doping Disciplinary Panel decides on 6 January 2017 to impose only a reprimand without a period of ineligibility on the Athlete including disqualification of his results.
